Results 171 to 180 of about 38,260 (246)

Evaluation of the clinical application of histamine H2 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting based on the attribute hierarchy model method. [PDF]

Front Pharmacol
Song J, Liu L, Meng B, Zhao H, Zhang P, Chen H, Wang Y.   +6 more
europepmc   +1 more source

Development of 3D printed dexamethasone chewable tablets for prophylaxis of chemotherapy-induced nausea and vomiting in children. [PDF]

Int J Pharm X
Dadkhah A, Gutowski T, Wansing EM, von Hugo A, Woessmann W, Winkler B, Franke G, Baehr M, Langebrake C.   +8 more
europepmc   +1 more source

Comparative efficacy of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists with or without dexamethasone for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy (HEC): a network meta-analysis. [PDF]

PeerJ
Xu H, Xing J, Yang S, Rong L, Liu L, Chen X.   +5 more
europepmc   +1 more source

Efficacy of cannabinoids for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis. [PDF]

Support Care Cancer
Chow R, Basu A, Kaur J, Hui D, Im J, Prsic E, Boldt G, Lock M, Eng L, Ng TL, Zimmermann C, Scotte F.   +11 more
europepmc   +1 more source

Development and validation of a risk prediction model for acute chemotherapy-induced nausea and vomiting in pediatric patients with cancers. [PDF]

Transl Pediatr
Yu L, Wu Y, Lin N, Sun C, Zhou Y, Chu X, Guan L, Bai G, Zhu J.   +8 more
europepmc   +1 more source

Fosaprepitant for the prevention of multiple-day cisplatin chemotherapy-induced nausea and vomiting: a prospective randomized controlled study. [PDF]

BMC Pharmacol Toxicol
Wang L, Jin G, Wang W, Zhao J, Chen F, Li X, Jiang Y, Zhang Z, Li Q.   +8 more
europepmc   +1 more source

Incidence and Risk Factors of Platinum-Based Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. [PDF]

Curr Oncol
Jin K, Lin X, Xia X, Ye H, Yang D, Fan Y, Sun Q, Wang R.   +7 more
europepmc   +1 more source

Chemotherapy-induced nausea and vomiting

Annual Meeting of the Japanese Society of Toxicology, 2013
openaire   +1 more source

Olanzapine Versus Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Sarma I, Buragohain S, Lahon J, Banerjee P, Kumar S, Chetia R, Baishya P, Saikia D.   +7 more
europepmc   +1 more source

Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting. [PDF]

Future Oncol
Navari RM, Tyler T, Inui N, Iihara H, Bonizzoni E, Park YH, Rugo HS, Roeland EJ.   +7 more
europepmc   +1 more source